Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2799221000168119 | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, 1 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2799231000168116 | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Is a | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate | true | Inferred relationship | Some | ||
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1740834041 | |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | has intended active ingredient | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate | true | Inferred relationship | Some | 1740834040 | |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | has Australian BoSS | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate | true | Inferred relationship | Some | 1740834040 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, 2 vials | has MPUU | True | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Inferred relationship | Some | 1 |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, 5 vials | has MPUU | True | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Inferred relationship | Some | 1 |
| tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, 30 vials | has MPUU | True | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Inferred relationship | Some | 1 |
| Cardiolite 1 mg powder for injection, vial | Is a | True | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Inferred relationship | Some | |
| Technescan Sestamibi 1 mg powder for injection, vial | Is a | True | tetrakis(2-methoxyisobutylisonitrile) copper(1) tetrafluoroborate 1 mg injection, vial | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR